(From Reuters) An experimental malaria vaccine from GlaxoSmithKline provides African children with long-lasting protection, though its effectiveness declines slightly over time, according to recently published trial data. Scientists conducting the mid-stage trial at the Kenya Medical Research Institute said results showing the shot offered 46 percent protection for 15 months meant it had "promise as a potential public health intervention against childhood malaria in malaria endemic countries."
Patients and Patents's blog
Watching an interesting webcast of an event hosted by the Council for American Medical Innovation - Medical Innovation at the Crossroads: Choosing the Path Ahead.
Watch it live - event runs until 12:30 pm today.
A new study featured in the January issue of Health Affairs reaffirms the importance of medication adherence to patients’ health and overall treatment costs. The results of the study indicate that although improved medication adherence by people with four chronic vascular diseases increased pharmacy costs, it also produced substantial medical savings as a result of reductions in hospitalization and emergency department use.
Ahead of its symposium Wednesday (Medical Innovation at the Crossroads: Choosing the Path Ahead), the Council for American Medical Innovation released a Web video on the impact of medical innovation on American life and its potential (as reported by POLITICO Pulse). The symposium includes U.S.
mPedigree was recently announced as the Best Security Start-up in 2010 by the Global Security Challenge. mPedigree from Ghana is the first system in the world which enables consumers and patients to verify the authenticity of their medicines by sending a free text message of the unique, product-embossed codes.
The controversial study linking the measles mumps and rubella (MMR) vaccine to autism was based on falsified data and "manufactured at a London medical school," according to a report in the British Medical Journal. The investigative report includes a number of findings which suggest that the team at the Royal Free medical school, led by Andrew Wakefield, were not guilty of bad scientific practice but in fact engaged in deliberate fraud.
From the WHO’s photo story, 2010 in review: key health issues.
Control of neglected tropical diseases is feasible
Neglected tropical diseases thrive in impoverished settings, where housing is substandard, environments are contaminated with filth, and disease-spreading insects and animals abound.
From the WHO's photo story, 2010 in review: key health issues.
Drug-resistant tuberculosis at record high levels
Leaders of four committees in the US House of Representatives have introduced a bill -- Drug Safety Enhancement Act (Bill HR 6543) -- which would upgrade America’s prescription drug safety laws. This Bill proposes to equip the FDA with the authorities and resources it needs to adequately regulate the growing global marketplace for drugs.
HR 6543 would:
Bloomberg reports that Google Inc. and Microsoft Corp. are helping to establish a nonprofit organization targeting illegal Internet pharmacies in support of Obama administration efforts. The group is comprised of companies that serve as Internet choke points and was in response to a call from the administration for private efforts to police illegal pharmacies, said Victoria Espinel, the White House intellectual property enforcement coordinator.